Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ion I Mandoiu

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Experimental Medicine|September 24, 2014
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicityFei Duan, Jorge Duitama, Sahar Al Seesi, et al.
The Journal of Clinical Investigation|December 15, 2020
An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejectionCory A Brennick, Mariam M George, Marmar M Moussa, et al.
Nature Communications|November 6, 2021
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitopeHakimeh Ebrahimi-Nik, Marmar Moussa, Ryan P Englander, et al.
Genome Biology|February 9, 2020
Eleven grand challenges in single-cell data scienceDavid Lähnemann, Johannes Köster, Ewa Szczurek, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Experimental Medicine|September 24, 2014
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicityFei Duan, Jorge Duitama, Sahar Al Seesi, et al.
The Journal of Clinical Investigation|December 15, 2020
An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejectionCory A Brennick, Mariam M George, Marmar M Moussa, et al.
Nature Communications|November 6, 2021
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitopeHakimeh Ebrahimi-Nik, Marmar Moussa, Ryan P Englander, et al.
Genome Biology|February 9, 2020
Eleven grand challenges in single-cell data scienceDavid Lähnemann, Johannes Köster, Ewa Szczurek, et al.
Pageof 3